Roche-HIV.com
 
  Home | Disclaimer | Sitemap | Glossary | Library cart | Useful links | Keep me informed | Roche worldwide | Contact webmaster  
  
   Search this site
  Roche in HIV
  Understanding HIV
 
  About HIV
 
  Management issues
 
  Resistance
  Adherence
 
  Guidelines (HIV and HCV)
  Pharmaceutical products  
  Commitment to research  
  Commitment to access  
  Conferences  
  News and features
  Healthcare professionals

Pharmaceutical Products

Summary of product characteristics (SmPCs) documents are available below. Pharmaceutical products described in this section are all prescription-only medicines (POMs) and include:

FUZEON (enfuvirtide)

A fusion inhibitor for the treatment of HIV infection

FUZEON SmPC  [August 2004]

 

VIRACEPT (nelfinavir)

A protease inhibitor for the treatment of HIV infection

Viracept SmPC (all formulations) [August 2004]

 

FORTOVASE and INVIRASE (saquinavir)

Two different formulations of saquinavir, a protease inhibitor for the treatment of HIV infection

Fortovase SmPC  [August 2004]
Invirase SmPC 
 [August 2004]

 

HIVID (zalcitabine)

A reverse transcriptase inhibitor for the treatment of HIV infection

Hivid SmPC  [December 2002]

 

ROFERON-A (interferon alfa-2a)

Roferon-A is recombinant interferon alfa-2a for the treatment of various indications including AIDS-related Kaposi's sarcoma. It is available in different pharmaceutical forms and strengths. Here we only present the SmPC of the 3MIU vials for injection. For the SmPCs of the other available forms please send a request to the webmaster or contact your local Roche affiliate.

Roferon-A SmPC [June 2002]

 

PEGASYS (peginterferon alfa-2a [40KD])

PEGASYS is a pegylated form of interferon alfa-2a for the treatment of HCV infection.

Pegasys SmPC [February 2005]

 

COPEGUS (ribavirin)

COPEGUS is a guanosine analogue that is used in combination with interferon-based therapy for the treatment of hepatitis C virus infection

Copegus SmPC [February 2005]

 

CYMEVENE (ganciclovir)

Cymevene is used for the treatment of CMV infection.

Cymevene SmPC [September 2002]

 

VALCYTE (valganciclovir HCl tablets)

Valcyte is the oral pro-drug of Roche�s Cymevene (ganciclovir) used for the treatment of CMV infection.

Valcyte SmPC [June 2003]

Please note that information provided on any of the products listed above is NOT INTENDED FOR PHYSICIANS IN COUNTRIES WHERE THE PRODUCTS ARE NOT LICENSED FOR USE.
Before reviewing product information contained in this section, please consult your relevant regulatory authorities if you are unsure of the approval status of any of these products in your country.

If you have any questions regarding any Roche HIV products, please e-mail: basel.hiv-webmaster@roche.com.

« Back
Home | Disclaimer | Sitemap | Glossary | Library cart | Useful links | Keep me informed | Roche worldwide
All information contained in this website is generated and maintained by F. Hoffmann-La Roche, Ltd, Basel, Switzerland. This site is intended for use by physicians only. This site is not intended for residents of the United States of America.
Copyright 2006 F. Hoffmann La Roche Ltd.
Contact webmaster